Drugs or solutions used to clean the colon and get it ready for a colonoscopy procedure are known as colonoscopy bowel preparation drugs. To ensure a clean sight of the colon during the surgery, these oral medications empty the intestine by causing bowel movements and eliminating feces. Over the forecast period, the market growth is anticipated to be driven by the rising incidence of colorectal cancer. Additionally, increasing R&D efforts are anticipated to spur the market for bowel preparation medications for colonoscopies.
Global Colonoscopy Bowel Preparation Drugs Market is estimated to be valued at US$ 2000.5 million in 2023 and is expected to exhibit a CAGR of 4.9% during the forecast period (2023-2030).
Major Players in the Colonoscopy Bowel Preparation Drugs Industry:
1. Ferring B.V.
Ferring B.V. founded in 1950 and its headquarters Saint-Prex, Switzerland. The company operates in 50 countries. Ferring Pharmaceuticals today announced that the tailored dosing regimen in the PICOPREP
2. Bayer AG
Bayer AG founded in 1863, and its Headquarters located in Leverkusen, Germany. The company operates in 83 nations. In 2023 Bayer acquires U.S. company Asklepios BioPharmaceutical (AskBio) in December and launches a new platform for cell and
